RRC ID 70114
著者 Kodama S, Yoshii N, Ota A, Takeshita JI, Yoshinari K, Ono A.
タイトル Association between in vitro nuclear receptor-activating profiles of chemical compounds and their in vivo hepatotoxicity in rats.
ジャーナル J Toxicol Sci
Abstract The liver plays critical roles to maintain homeostasis of living organisms and is also a major target organ of chemical toxicity. Meanwhile, nuclear receptors (NRs) are known to regulate major liver functions and also as a critical target for hepatotoxic compounds. In this study, we established mammalian one-hybrid assay systems for five rat-derived NRs, namely PXR, PPARα, LXRα, FXR and RXRα, and evaluated a total of 326 compounds for their NR-activating profiles. Then, we assessed the association between their NR-activating profile and hepatotoxic endpoints in repeated-dose toxicity data of male rats from Hazard Evaluation Support System. In the in vitro cell-based assays, 68, 38, 20, 17 and 17 compounds were identified as positives for PXR, PPARα, LXRα, FXR and RXRα, respectively. The association analyses demonstrated that the PXR-positive compounds showed high frequency of endpoints related to liver hypertrophy, such as centrilobular hepatocellular hypertrophy, suggesting that PXR activation is involved in chemical-induced liver hypertrophy in rats. It is intriguing to note that the PXR-positive compounds also showed statistically significant associations with both prolonged activated partial thromboplastin time and prolonged prothrombin time, suggesting a possible involvement of PXR in the regulation of blood clotting factors. Collectively, our approach may be useful for discovering new functions of NRs as well as understanding the complex mechanism for hepatotoxicity caused by chemical compounds.
巻・号 46(12)
ページ 569-587
公開日 2021-1-1
DOI 10.2131/jts.46.569
PMID 34853243
MeSH Animals Chemical and Drug Induced Liver Injury* / etiology Hepatomegaly Liver Male Pregnane X Receptor Rats Receptors, Cytoplasmic and Nuclear Receptors, Steroid*
IF 1.737
リソース情報
ヒト・動物細胞 Hep G2(RCB1648) Hep G2(RCB1886)